Neuroendocrine modulation of cancer progression
- PMID: 18638541
- PMCID: PMC2630522
- DOI: 10.1016/j.bbi.2008.06.007
Neuroendocrine modulation of cancer progression
Abstract
Clinical and animal studies now support the notion that psychological factors such as stress, chronic depression, and lack of social support might promote tumor growth and progression. Recently, cellular and molecular studies have started to identify biological processes that could mediate such effects. This review provides a mechanistic understanding of the relationship between biological and behavioral influences in cancer and points to more comprehensive behavioral and pharmacological approaches for better patient outcomes.
Figures

References
-
- Basu S, Nagy JA, Pal S, Vasile E, Eckelhoefer IA, Bliss VS, Manseau EJ, Dasgupta PS, Dvorak HF, Mukhopadhyay D. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med. 2001;7:569–574. - PubMed
-
- Bleiker EM, Hendriks JH, Otten JD, Verbeek AL, van der Ploeg HM. Personality factors and breast cancer risk: a 13-year follow-up. J Natl Cancer Inst. 2008;100:213–218. - PubMed
-
- Bos JL. Epac proteins: multi-purpose cAMP targets. Trends Biochem Sci. 2006;31:680–686. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources